Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge
Published in
Anticancer Research: International Journal of Cancer Research and Treatment, April 2021
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2021.
All research outputs
#28,641,956
of 34,412,533 outputs
Outputs from Anticancer Research: International Journal of Cancer Research and Treatment
#6,282
of 8,157 outputs
Outputs of similar age
#378,091
of 481,990 outputs
Outputs of similar age from Anticancer Research: International Journal of Cancer Research and Treatment
#78
of 103 outputs
Altmetric has tracked 34,412,533 research outputs across all sources so far. This one is in the 9th percentile – i.e., 9% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,157 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 481,990 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
